Given the involvement of HMGB1 in the inflammatory response, tumorigenesis, and allograft rejection [56–58], and its contribution to the progression of bladder cancer [59–62], we investigated the relationship between IGF2BP3 and HMGB1. Here, IGF2BP3 is linked to urinary bladder cancer.